Goldman Sachs raised the firm’s price target on Oracle (ORCL) to $195 from $145 and keeps a Neutral rating on the shares. The company’s revenue and operating margins for Q4 topped estimates, but while its aggressive investment in CapEx is a welcome evidence of strong demand, the firm also questions whether the $25B in FY26 will be enough, noting that the ramping depreciation may constrain potential earnings power over the mid-term, especially if revenue growth targets prove aspirational, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
